What if you can pop an "exercise" pill daily which mimics the health benefits of running, weight training or endurance exercise to keep you fit and disease-free?
It does not seem a far-fetched idea as researchers from the University of Sydney have provided the world's first comprehensive exercise blueprint that may pave the way for drugs that mimic the benefits of exercise in the near future.
They exposed 1,000 molecular changes that occur in our muscles when we exercise, opening the door for drug treatments to mirror the health benefits of exercise.
"Exercise is the most powerful therapy for many human diseases, including Type 2 diabetes, cardiovascular disease and neurological disorders," said professor David James from the University of Sydney's Charles Perkins Centre.
However, for many people, exercise is not a viable treatment option.
"This means it is essential we find ways of developing drugs that mimic the benefits of exercise," he added.
The team, in collaboration with researchers from the University of Copenhagen in Denmark, analysed human skeletal muscle biopsies from four untrained, healthy males following 10 minutes of high intensity exercise.
Using a technique known as mass spectrometry to study a process called protein phosphorylation, they discovered that short, intensive exercise triggers more than 1,000 changes.
Most traditional drugs target individual molecules.
"With this exercise blueprint we have proven that any drug that mimics exercise will need to target multiple molecules and possibly even pathways," the authors pointed out.
The majority of changes they discovered have not previously been associated with exercise, with existing research focusing on just a small number of changes.
"Exercise produces an extremely complex, cascading set of responses within human muscle. It plays an essential role in controlling energy metabolism and insulin sensitivity," noted co-author Dr Nolan Hoffman from the Charles Perkins Centre.
The researchers have narrowed down the therapeutic possibilities within the blueprint using mathematical and engineering-based analysis.
"This is a major breakthrough, as it allows scientists to use this information to design a drug that mimics the true beneficial changes caused by exercise," the team concluded.
The research was published in the journal Cell Metabolism.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
